Fund comparison · from official SEC filings
CANC vs XBI: how much do they overlap?
Tema Oncology ETF and State Street(R) SPDR(R) S&P(R) Biotech ETF
vs
Shared holdings
Company
CANC
XBI
R
RVMDREVOLUTION MEDICINES INC
7.72%
1.03%
C
COGTCOGENT BIOSCIENCES INC
4.09%
1.13%
I
IMNMIMMUNOME INC
3.91%
0.80%
C
CELCCELCUITY INC
3.58%
1.04%
?
—Nuvalent Inc
3.37%
1.08%
A
ABBVABBVIE INC
2.80%
1.01%
E
EXELEXELIXIS INC
2.77%
1.08%
B
BBIOBRIDGEBIO PHARMA INC
2.75%
1.10%
C
CGONCG ONCOLOGY INC
2.43%
1.08%
I
IDYAIDEAYA BIOSCIENCES INC
2.27%
0.68%
A
AMGNAMGEN INC
2.11%
0.98%
R
RLAYRELAY THERAPEUTICS INC
1.28%
0.35%
H
HALOHALOZYME THERAPEUTICS INC
1.23%
1.03%
S
SMMTSUMMIT THERAPEUTICS INC
1.20%
1.15%
R
RCUSARCUS BIOSCIENCES INC
1.20%
0.58%
G
GILDGILEAD SCIENCES INC
1.12%
1.01%
E
ERASERASCA INC
1.08%
0.95%
N
NTRANATERA INC
0.54%
1.07%
R
REGNREGENERON PHARMACEUTICALS
0.75%
1.05%
A
ANABANAPTYSBIO INC
0.99%
0.35%
S
SNDXSYNDAX PHARMACEUTICALS INC
0.80%
0.68%
C
CRVSCORVUS PHARMACEUTICALS INC
0.76%
0.39%
A
AVBPARRIVENT BIOPHARMA INC
0.73%
0.20%
I
IOVAIOVANCE BIOTHERAPEUTICS INC
0.65%
0.36%
I
INBXINHIBRX BIOSCIENCES INC
0.60%
0.25%
Only in CANC
L
LLYELI LILLY & CO
4.82%
R
RHHBYROCHE HOLDINGS LTD-SPONS ADR
4.21%
N
NVSEFNOVARTIS AG-REG
4.03%
M
MRKMERCK & CO. INC.
3.57%
A
AZNASTRAZENECA PLC
3.53%
B
BMYBRISTOL-MYERS SQUIBB CO
3.30%
L
LEGNLEGEND BIOTECH CORP-ADR
2.99%
J
JNJJOHNSON & JOHNSON
2.54%
G
GMABGENMAB A/S -SP ADR
2.37%
Z
ZLABZAI LAB LTD-ADR
1.98%
O
ONCBEONE MEDICINES LTD-ADR
1.88%
Z
ZYMEZYMEWORKS INC
1.51%
E
ELVNENLIVEN THERAPEUTICS INC
1.31%
I
IMTXIMMATICS NV
1.12%
F
FXFXXFIRST AM TREAS OBLI-X
1.09%
N
NUVBNUVATION BIO INC
1.07%
U
URGNUROGEN PHARMA LTD
0.93%
G
GHGUARDANT HEALTH INC
0.81%
C
CHGCFCHUGAI PHARMACEUTICAL CO LTD
0.67%
T
TRAXFIRST TRACKS BIOTHERAPEUTICS
0.53%
I
IMCRIMMUNOCORE HOLDINGS PLC-ADR
0.51%
B
BBOTBRIDGEBIO ONCOLOGY THERAPEUT
0.47%
H
HCMHUTCHMED CHINA-ADR
0.44%
A
ARVNARVINAS INC
0.43%
A
ANLADLAI NORTYE LTD-ADR
0.30%
Only in XBI
G
GVMXXSTATE ST INST US GOV MM-PREM
7.47%
1
1JKAPELLIS PHARMACEUTICALS INC
1.70%
A
ALKSALKERMES PLC
1.34%
M
MDGLMADRIGAL PHARMACEUTICALS INC
1.28%
T
TGTXTG THERAPEUTICS INC
1.25%
I
INSMINSMED INC
1.24%
S
SRRKSCHOLAR ROCK HOLDING CORP
1.20%
A
APGEAPOGEE THERAPEUTICS INC
1.19%
P
PTGXPROTAGONIST THERAPEUTICS INC
1.15%
U
UTHRUNITED THERAPEUTICS CORP
1.15%
P
PRAXPRAXIS PRECISION MEDICINES I
1.14%
A
ARWRARROWHEAD PHARMACEUTICALS IN
1.14%
P
PTCTPTC THERAPEUTICS INC
1.09%
C
CYTKCYTOKINETICS INC
1.09%
A
ALNYALNYLAM PHARMACEUTICALS INC
1.09%
K
KYMRKYMERA THERAPEUTICS INC
1.08%
N
NBIXNEUROCRINE BIOSCIENCES INC
1.07%
T
TWSTTWIST BIOSCIENCE CORP
1.07%
K
KRYSKRYSTAL BIOTECH INC
1.07%
P
PCVXVAXCYTE INC
1.07%
M
MIRMMIRUM PHARMACEUTICALS INC
1.06%
A
AM6AMICUS THERAPEUTICS INC
1.06%
I
IONSIONIS PHARMACEUTICALS INC
1.06%
T
TVTXTRAVERE THERAPEUTICS INC
1.06%
A
ACLXARCELLX INC
1.06%
Hold CANC and XBI together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Other comparisons you might like
XBI vs LABUDirexion Daily S&P Biotech Bull 3X Shares
75% overlap
XBI vs BIPIXBIOTECHNOLOGY ULTRASECTOR PROFUND
70% overlap
XBI vs IBBQInvesco Nasdaq Biotechnology ETF
36% overlap
XBI vs BIBProShares Ultra Nasdaq Biotechnology
32% overlap
XBI vs IBBiShares Biotechnology ETF
32% overlap
CANC vs PRHSXT. Rowe Price Health Sciences Fund, Inc.
28% overlap
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.
Informational and educational only — not investment advice.